Feminizing Hormones

Feminizing hormones are medications (e.g. estrogen, anti-androgens, progestins) used to develop physical characteristics that are in line with one's gender identity or gender expression.

This page sets out the advantages and disadvantages of common estrogen, testosterone blocker and progesterone therapies, as well as the expected effects and potential risks of feminizing hormones. The list of therapies is not exhaustive. Talk to your health care provider to determine the best fit for you.

Common therapies

Your health care provider will help you tailor your hormone therapy to meet your goals, health needs and budget. Your hormone therapy may include any of the following:

  • estrogen alone
  • estrogen and testosterone blockers
  • estrogen and testosterone blockers and progesterone
  • testosterone blockers alone (this is not safe for long periods of time)

Common estrogen therapies

Oral estrogen 

  • brand name: Estrace 
  • description: a pill you swallow or dissolve under your tongue each day
  • advantages: less expensive (around $14 a month)
  • disadvantages: higher cardiovascular risk for people over 40, especially with other risk factors

Estrogen patch 

  • brand names: Estradot, Estraderm, Oesclim
  • description: a patch you wear on your skin that gets changed twice a week
  • advantages: lower cardiovascular risk for people over 40, especially with other risk factors
  • disadvantages: more expensive (around $25 a month). some people have a skin reaction to the adhesive in the patch

Injectable estrogen (estradiol valerate)

  • description: a substance you inject every two weeks
  • advantages: possibly lower cardiovascular risk for people over 40, especially with other risk factors
  • disadvantages: more expensive and less widely available. some people find injections to be painful. improper injection can be dangerous

Common testosterone blocker therapies

Spironolactone 

  • brand name: Aldactone
  • description: a pill that you swallow once or twice a day
  • advantages: most common because it’s less expensive ($22 a month) and usually well tolerated
  • disadvantages: some people find pills hard to swallow. may make you have to pee more often and may require dietary restrictions

Cyproterone 

  • brand name: Androcur
  • description: a pill that you swallow once a day
  • advantages: potent testosterone blocker
  • disadvantages: more expensive (around $50 a month). may cause liver inflammation, especially in higher doses, and depression

Finasteride 

  • brand name: Proscar
  • description: a pill that you put under your tongue once a day or every other day. usually used with an anti-androgen therapy
  • advantages: can help slow hereditary hair loss
  • disadvantages: costs around $60 a month

Common progesterone therapies

The use of progesterone in feminizing regimens is controversial. Most guidelines do not recommend the use of it as part of a standard regimen but discuss the possibility of using it as an adjunctive medication for a period of time.

Benefits may include positive effects on the development of the nipple and areola and improved libido, but this is unproven. 

Common side effects include weight gain, edema, lipid changes and depression. Taking progesterone along with estrogen as compared to taking estrogen alone is believed to increase the risk of strokes, pulmonary emboli, breast cancer and heart disease. 

Medroxyprogesterone 

  • brand name: Provera
  • description: a pill you take daily
  • advantages: widely available and less expensive at around $33 a month. may help with breast development, although this is controversial
  • disadvantages: thought to be higher risk

Micronized progesterone 

  • brand name: Prometrium
  • description: a pill you take daily
  • advantages: thought to be lower risk than medroxyprogesterone
  • disadvantages: more expensive at about $90 a month
Effects

Expected effects of feminizing hormone therapies

Breast development

  • usually starts in 3 to 6 months
  • breasts reach full size in 2 to 3 years
  • size varies; A or B cup size is typical
  • a  permanent change

Body fat redistribution

  • usually starts in 3 to 6 months
  • reaches maximum effect in 2 to 5 years
  • less fat on abdomen
  • more fat on buttocks, hips and thighs
  • not a permanent change if you stop taking hormones

Reduced muscle mass & strength

  • usually starts in 3 to 6 months
  • reaches maximum effect in 1 to 2 years
  • reduced muscle and strength in upper body
  • not a permanent change if you stop taking hormones

Softening of skin

  • usually starts in 3 to 6 months
  • skin will be softer and less oily
  • not a permanent change if you stop taking hormones

Less facial & body hair

  • usually starts in 6 to 12 months
  • maximum effect in more than 3 years
  • body hair will appear less noticeable
  • body hair will grow more slowly
  • beard and mustache may grow more slowly and appear less noticeable, but will not go away
  • if you have male pattern hair loss, it may slow down
  • hair that has already been lost likely will not grow back
  • not a permanent change if you stop taking hormones

Reduced sex drive

  • usually starts in 1 to 3 months
  • reaches maximum effect in 1 to 2 years
  • fewer morning erections
  • fewer spontaneous erections
  • not a permanent change if you stop taking hormones

Fertility

  • timeline varies
  • sperm may no longer reach maturity
  • won’t produce as much semen
  • may not be able to get hard enough for penetrative sex
  • may become permanently unable to make someone pregnant (but birth control is still recommended)

Smaller gonads (testes)

  • usually starts in 3 to 6 months
  • maximum effect in 2 to 3 years
  • may shrink down to half their initial size
  • may or may not be a permanent change if you stop taking hormones

Emotional changes

  • overall emotional state may or may not change; this varies from person to person
  • may experience a narrower or wider range of emotions or feelings

External video resource

A presentation by Dr. Maddie Deutsch, from the Center of Excellence for Transgender Health.

Risks

Risks associated with feminizing hormone therapies

With feminizing hormone therapies, there is: 

  • a likely increased risk of serious blood clots (venous thromboembolic disease), gallstones, elevated liver enzymes, weight gain and hypertriglyceridemia (risk factor for heart disease and pancreas problems)
  • a likely increased risk (with presence of additional risk factors) of cardiovascular disease
  • a possible increased risk of high blood pressure (hypertension), hyperprolactinemia or prolactinoma 
  • a possible increased risk (with presence of additional risk factors) of type 2 diabetes

There is either no increased risk of breast cancer or the research is inconclusive. 

Mood changes are variable; they may be positive or negative, or may have an adjustment period. Many people experience positive mood changes after starting hormone therapy. Any mood changes that cause you concern should be discussed with your primary care provider.

Tab Heading
SOURCE: Feminizing Hormones ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © Provincial Health Services Authority. All Rights Reserved.

    Copyright © 2018 Provincial Health Services Authority